ＪＣＲファーマ(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4552/E00973JCR Pharmaceuticals Co., Ltd.
公表日公表担保新規貸付前週比新規借入（自己）前週比新規借入（転貸）前週比
2020/03/13日証協無担保500株-66.67%0株0%1,401株+39.96%
2020/03/13日証協有担保37,052株-28.03%23,602株-63.12%73,513株-0.15%
2020/03/06日証協無担保1,500株+114.29%0株0%1,001株-37.44%
2020/03/06日証協有担保51,484株-50.54%64,001株+270.12%73,621株+20.5%
2020/02/28日証協無担保700株-56.25%0株0%1,600株-0.93%
2020/02/28日証協有担保104,099株+44.94%17,292株-69.99%61,097株+10.8%
2020/02/21日証協無担保1,600株0%0株0%1,615株+9999.99%
2020/02/21日証協有担保71,822株-48.45%57,625株+111.86%55,142株+70.2%
2020/02/14日証協無担保0株0%0株-100%3株-99.73%
2020/02/14日証協有担保139,330株-7.47%27,200株+94.29%32,398株-52.94%
2020/02/07日証協無担保0株0%303株0%1,101株+171.18%
2020/02/07日証協有担保150,586株+37.67%14,000株-52.55%68,850株+122.82%
2020/01/31日証協無担保0株-100%0株-100%406株-71.1%
2020/01/31日証協有担保109,381株+463.09%29,502株+315.52%30,900株+65.24%
2020/01/24日証協無担保1,100株+175%203株+6666.67%1,405株-92.84%
2020/01/24日証協有担保19,425株-83.92%7,100株-58.25%18,700株-68.85%
2020/01/17日証協無担保400株-42.86%3株0%19,613株+4778.86%
2020/01/17日証協有担保120,787株-50.81%17,004株-62.3%60,030株+5.2%
2020/01/10日証協無担保700株+600%0株-100%402株+34%
2020/01/10日証協有担保245,569株+728.37%45,104株+338.75%57,063株+325.84%
2019/12/30日証協無担保100株0%400株-33.33%300株-95.71%
2019/12/30日証協有担保29,645株-75.26%10,280株-74.08%13,400株-58.46%
2019/12/27日証協無担保100株-99.76%600株0%7,000株+900%
2019/12/27日証協有担保119,826株-7.47%39,660株+141.53%32,257株-24.78%
2019/12/20日証協無担保42,000株0%0株0%700株0%
2019/12/20日証協有担保129,504株-7.59%16,420株+134.57%42,885株+50.78%
2019/12/13日証協無担保0株-100%0株0%700株-22.22%
2019/12/13日証協有担保140,136株-27.81%7,000株-76.31%28,442株-41.41%
2019/12/06日証協無担保9,260株0%0株0%900株+800%
2019/12/06日証協有担保194,126株-23.11%29,548株+46.65%48,545株-30.25%
2019/11/29日証協無担保0株0%0株0%100株-75%
2019/11/29日証協有担保252,481株-6.93%20,148株-40.39%69,600株+46.53%
2019/11/22日証協無担保0株0%0株0%400株-63.8%
2019/11/22日証協有担保271,271株+14.14%33,800株+374.65%47,498株+9.95%
2019/11/15日証協無担保0株0%0株0%1,105株+37.78%
2019/11/15日証協有担保237,674株+101.47%7,121株-85.4%43,200株-41.07%
2019/11/08日証協無担保0株0%0株0%802株+59.76%
2019/11/08日証協有担保117,968株+11.52%48,778株+339.12%73,302株+851.97%

※株式分割は考慮していませんのでご注意ください。

Page Top